Clinical Trial Update: Immune Response After SARS-CoV-2 (COVID-19) Vaccination in a Context of Non-Hodgkin Lymphoma [NA]

View source ↗

Summary

This update summarizes immune responses to COVID-19 vaccination in patients with Non-Hodgkin lymphoma, with the trial status listed as terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Snippet

Sponsor: Versailles Hospital | Conditions: Non-hodgkin Lymphoma,B Cell, Vaccination Failure | NA | Status: TERMINATED